Aug 10 |
Iovance Biotherapeutics Second Quarter 2024 Earnings: Beats Expectations
|
Aug 9 |
Why Iovance Biotherapeutics Shares Are Soaring Today
|
Aug 9 |
Iovance soars 17% as 2024 and 2025 revenue guidance well above consensus
|
Aug 9 |
Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View
|
Aug 9 |
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
|
Aug 9 |
Iovance Biotherapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
Aug 9 |
Iovance Biotherapeutics, Inc. (IOVA) Q2 2024 Earnings Call Transcript
|
Aug 8 |
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
|
Aug 8 |
Iovance Biotherapeutics: Q2 Earnings Snapshot
|
Aug 8 |
Iovance Biotherapeutics GAAP EPS of -$0.34 beats by $0.01, revenue of $31.1M beats by $6.54M
|